Page last updated: 2024-10-26

etizolam and Chronic Disease

etizolam has been researched along with Chronic Disease in 2 studies

etizolam: structure given in first source

Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).

Research Excerpts

ExcerptRelevanceReference
"Thirty out-patients suffering from panic disorders associated with agoraphobia were enrolled in a double-blind, controlled trial to compare the effectiveness and tolerability of etizolam and placebo."9.06Etizolam versus placebo in the treatment of panic disorder with agoraphobia: a double-blind study. ( Ecari, U; Savoldi, F; Somenzini, G, 1990)
"Thirty out-patients suffering from panic disorders associated with agoraphobia were enrolled in a double-blind, controlled trial to compare the effectiveness and tolerability of etizolam and placebo."5.06Etizolam versus placebo in the treatment of panic disorder with agoraphobia: a double-blind study. ( Ecari, U; Savoldi, F; Somenzini, G, 1990)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Narita, M1
Kaneko, C1
Miyoshi, K1
Nagumo, Y1
Kuzumaki, N1
Nakajima, M1
Nanjo, K1
Matsuzawa, K1
Yamazaki, M1
Suzuki, T1
Savoldi, F1
Somenzini, G1
Ecari, U1

Trials

1 trial available for etizolam and Chronic Disease

ArticleYear
Etizolam versus placebo in the treatment of panic disorder with agoraphobia: a double-blind study.
    Current medical research and opinion, 1990, Volume: 12, Issue:3

    Topics: Adult; Agoraphobia; Chronic Disease; Diazepam; Double-Blind Method; Drug Administration Schedule; Fe

1990

Other Studies

1 other study available for etizolam and Chronic Disease

ArticleYear
Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2006, Volume: 31, Issue:4

    Topics: Amygdala; Analgesics, Opioid; Analysis of Variance; Animals; Anxiety; Behavior, Animal; Benzamides;

2006